Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-01-28 Cantley Lewis Clayton Jr. Director Sale −625 $44.33 $28K 132,340
2016-01-07 Biller Scott Chief Scientific Officer Exercise or conversion +15,000 $0.47 $7K 49,070
2016-01-07 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −15,000 293,471
2016-01-07 Schenkein David P Chief Executive Officer Exercise or conversion +20,000 $0.30 $6K 272,272
2016-01-07 Schenkein David P Chief Executive Officer Exercise or conversion · Stock option (right to buy) −20,000 895,501
2016-01-05 Schenkein David P Chief Executive Officer Exercise or conversion +10,000 $0.30 $3K 252,272
2016-01-05 Schenkein David P Chief Executive Officer Exercise or conversion · Stock option (right to buy) −10,000 915,501
2016-01-04 Higgons John Duncan Chief Operating Officer Exercise or conversion +57,024 $2.34 $133K 118,859
2016-01-04 Higgons John Duncan Chief Operating Officer Exercise or conversion +1,975 $31.64 $62K 120,834
2016-01-04 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −57,024 182,088
2016-01-04 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −1,975 180,113
2016-01-04 Schenkein David P Chief Executive Officer Exercise or conversion +10,000 $0.30 $3K 242,272
2016-01-04 Schenkein David P Chief Executive Officer Exercise or conversion · Stock option (right to buy) −10,000 925,501
2015-12-31 Biller Scott Chief Scientific Officer Exercise or conversion +5,500 $31.64 $174K 39,570
2015-12-31 Biller Scott Chief Scientific Officer Sale −5,500 $65.27 $359K 34,070
2015-12-31 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −5,500 308,471
2015-12-29 Cantley Lewis Clayton Jr. Director Sale −2,670 $66.16 $177K 132,967
2015-12-29 Cantley Lewis Clayton Jr. Director Sale −2,670 $66.11 $177K 132,965
2015-12-28 Cantley Lewis Clayton Jr. Director Sale −2,662 $63.73 $170K 135,637
2015-12-28 Cantley Lewis Clayton Jr. Director Sale −2,662 $63.72 $170K 135,635

Page 83 of 93 · 1,853 trades